Cargando…
Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers
Among healthcare workers (HCWs), SARS-CoV-2 vaccine hesitancy may be linked to a higher susceptibility to nocebo effects, i.e., adverse events (AEs) experienced after medical treatments due to negative expectations. To investigate this hypothesis a cross-sectional survey was performed with a self-co...
Autores principales: | Mitsikostas, Dimos D., Aravantinou-Fatorou, Konstantina, Deligianni, Christina, Kravvariti, Evrydiki, Korompoki, Eleni, Mylona, Maria, Vryttia, Pinelopi, Papagiannopoulou, Georgia, Delicha, Eumorphia-Maria, Dellis, Athanasios, Tsivgoulis, Georgios, Dimopoulos, Meletios A., Amanzio, Martina, Sfikakis, Petros P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541064/ https://www.ncbi.nlm.nih.gov/pubmed/34696287 http://dx.doi.org/10.3390/vaccines9101179 |
Ejemplares similares
-
The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019) -
Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic
por: Fragoulis, George E., et al.
Publicado: (2020) -
Editorial: Nocebo Effects and Their Influence on Clinical Trials and Practice: Modulating Factors in Healthy and Pathological Conditions
por: Amanzio, Martina, et al.
Publicado: (2020) -
EHMTI-0331. Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultation
por: Deligianni, C, et al.
Publicado: (2014) -
Nocebo in Biosimilars and Generics in Neurology: A Systematic Review
por: Spanou, Ioanna, et al.
Publicado: (2019)